Recent studies have demonstrated that shikonin has been shown to control pyruvate kinase type M2 (PKM2), which in turn causes apoptosis and inhibits proliferation and glycolysis in HCC cells [44,45,46]. The gene discussed is PKM; the disease is hepatocellular carcinoma.